Lexapro vs Zoloft: Which SSRI Is Right for You?

Escitalopram is the most selective SSRI on the market. It is the pure S-enantiomer of citalopram — chemists separated the two mirror-image molecules of the original drug and isolated the one responsible for SSRI activity. The R-enantiomer, which mainly contributes to off-target receptor binding and side effects, was removed entirely.

The result is an SSRI with less activity at histamine, adrenergic, and muscarinic receptors than most of its class peers. In practice, this tends to translate to a side effect profile that many patients find clean and predictable. It also has very mild effects on cytochrome P450 enzymes, making it a sensible choice when a patient is already managing other medications.

FDA approvals are narrower than Zoloft — only major depressive disorder and generalized anxiety disorder — but prescribers use it off-label for other anxiety presentations given its clinical profile. Its 5mg strength option also makes low-strength titration straightforward.

Sertraline is the most commonly prescribed SSRI in the world. Its defining clinical advantage is breadth: six distinct FDA-approved indications covering depression, OCD, PTSD, panic disorder, social anxiety disorder, and PMDD. When a prescriber needs to cover multiple potential diagnoses under one medication, Zoloft is often the default reach.

Its half-life of around 26 hours supports stable once-daily blood levels. It is a mild-to-moderate CYP2D6 inhibitor — more than Lexapro but considerably less so than paroxetine — making drug interactions a consideration but not a major barrier in most cases.

GI side effects, particularly nausea and loose stools early in treatment, are among the most commonly reported complaints with Zoloft. These typically improve within the first two to four weeks as the body adjusts. Zoloft also has more accumulated human pregnancy data than escitalopram and is frequently named as the preferred SSRI when treatment is indicated during pregnancy.